全球细胞治疗製造市场按治疗类型、技术类型、製造目的、应用和地区划分

2025 年全球细胞治疗製造市场规模预估为 56.5 亿美元，预计到 2032 年将达到 151.4 亿美元，2025 年至 2032 年的复合年增长率为 15.1%。

图。

近年来，由于心臟疾病等慢性疾病的发生率不断上升，全球细胞疗法製造市场经历了显着增长。与传统药物相比，细胞疗法是多种疾病的更有效的治疗选择。在预计预测期内，细胞治疗製造技术的进步和政府对细胞研究的支持（尤其是美国和欧洲的政府支持）将推动市场成长。然而，开发和製造细胞疗法的高成本可能会阻碍市场成长。

市场动态：

全球细胞治疗製造市场的成长受到心臟疾病等慢性疾病日益普及的推动。细胞治疗製造技术的进步使得高效、大规模生产成为可能，推动了市场成长。各主要市场的政府都透过资金补助和监管指南支持以细胞为基础的研究，这为市场参与者创造了机会。然而，从实验室到商业化的细胞疗法开发高成本可能会阻碍市场成长。参与企业需要大量的资本投入，这阻碍了市场的成长。细胞处理专家的短缺也阻碍了市场的成长。公司之间持续的併购为近期提供了潜在的成长机会。

本研究的主要特点

• 本报告对全球细胞治疗製造市场进行了详细分析，并以 2024 年为基准年，展示了预测期（2025-2032 年）的市场规模和复合年增长率。
• 它还强调了各个领域的潜在收益成长机会，并说明了该市场的引人注目的投资提案矩阵。
• 它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
• 全球细胞治疗製造市场的主要企业根据公司亮点、产品系列、关键亮点、绩效和策略等参数进行分析。
• 主要企业包括药明康德、Lonza、Merck KGaA、Takara Bio、住友大日本製药、富士FUJIFILM Holdings、赛默飞Astellas製药、OXGENE、Cytiva、Exothera、Charles River Laboratories、Cell Therapies Pty Ltd、Bio-Techne 和 Catalent, Inc.
• 本报告的见解可以帮助负责人和企业经营团队就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 全球细胞疗法製造市场迎合了该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员可以透过用于分析全球细胞治疗製造市场的各种策略矩阵来简化决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 影响分析
• 市场趋势
• 主要进展
• 监管情景
• 收购和合作场景
• 资金筹措和投资
• PEST分析
• 波特的分析

第 4 章。

• 整体影响
• 政府倡议
• COVID-19 市场影响

5. 全球细胞治疗製造市场按治疗类型划分（2020-2032 年）

• 同种异体细胞治疗
• 自体细胞治疗

6. 全球细胞治疗製造市场按技术类型划分（2020-2032 年）

• 体细胞技术
• 细胞永生化技术
• 病毒载体技术
• 基因组编辑技术
• 细胞可塑性技术
• 3D 技术

7. 全球细胞治疗製造市场依製造目的划分（2020-2032 年）

• 临床
• 商业的
• 临床前

8. 全球细胞治疗製造市场按应用划分（2020-2032 年）

• 肌肉骨骼
• 心血管
• 胃肠道
• 神经系统
• 肿瘤学
• 皮肤科
• 其他的

9. 全球细胞治疗製造市场（按地区划分） (2020-2032)

• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东
• 非洲

第十章 竞争格局

• 公司简介
  • WuXi AppTec, Inc.
  • Lineage Cell Therapeutics, Inc.
  • Healios Ltd.
  • Lonza
  • Merck KGaA
  • Takara Bio Inc.
  • Sumitomo Dainippon Pharma Co., LTD.
  • Fujifilm Holdings Corporation
  • Thermo Fisher Scientific, Inc.
  • Astellas Pharma Inc.
  • OXGENE
  • Cytiva
  • Exothera
  • Charles River Laboratories
  • Cell Therapies Pty Ltd
  • Bio-Techne
  • Catalent, Inc

第 11 章 分析师建议

• 命运之轮
• 分析师观点
• Coherent Opportunity Map（COM）

第 12 章参考文献与调查方法

• 参考
• 调查方法

Global Cell Therapy Manufacturing Market is estimated to be valued at USD 5.65 Bn in 2025 and is expected to reach USD 15.14 Bn by 2032, growing at a compound annual growth rate (CAGR) of 15.1% from 2025 to 2032.

Figure. Cell Therapy Manufacturing Market Share (%), By Region 2025

Global cell therapy manufacturing market has been witnessing significant growth in the recent years, owing to growing prevalence of chronic diseases such as cancer and cardiac disorders. Cell therapies are more effective treatment options for various conditions as compared to traditional drugs. The advancement in cell therapy manufacturing technology and government support for cell-based research especially in the U.S. and Europe are projected to drive the market growth during the forecast period. However, high costs associated with cell therapy development and manufacturing can hamper the market growth.

Market Dynamics:

Global cell therapy manufacturing market growth is driven by growing prevalence of chronic diseases such as cancer and cardiac disorders. Advancements in cell therapy manufacturing technologies enable efficient and large-scale production, and this drives the market growth. Various governments across major markets are supporting cell-based research through funding and regulatory guidelines, and this offers opportunities for market players. However, high costs associated with cell therapy development from laboratory to commercialization can hamper the growth of market. Market players require huge capital investments, and this hampers the market growth. Lack of skilled professionals for cell processing also hampers the market growth. Ongoing mergers and acquisitions among players provides potential growth opportunities in the near future.

Key Features of the Study:

• This report provides an in-depth analysis of the global cell therapy manufacturing market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global cell therapy manufacturing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this includes WuXi AppTec, Inc., Lineage Cell Therapeutics, Inc., Healios Ltd. , Lonza, Merck KGaA, Takara Bio Inc., Sumitomo Dainippon Pharma Co., LTD., Fujifilm Holdings Corporation, Thermo Fisher Scientific, Inc., Astellas Pharma Inc., OXGENE, Cytiva, Exothera, Charles River Laboratories, Cell Therapies Pty Ltd, Bio-Techne, Catalent, Inc
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global cell therapy manufacturing market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell therapy manufacturing market.

Detailed Segmentation-

• By Therapy Type:
  • Allogeneic Cell Therapy
  • Autologous Cell Therapy
• By Technology Type:
  • Somatic Cell Technology
  • Cell Immortalization Technology
  • Viral Vector Technology
  • Genome Editing Technology
  • Cell Plasticity Technology
  • 3D Technology
• By Manufacturing Purpose:
  • Clinical
  • Commercial
  • Pre-clinical
• By Application:
  • Musculoskeletal
  • Cardiovascular
  • Gastrointestinal
  • Neurological
  • Oncology
  • Dermatology
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • WuXi AppTec, Inc.
  • Lineage Cell Therapeutics, Inc.
  • Healios Ltd.
  • Lonza
  • Merck KGaA
  • Takara Bio Inc.
  • Sumitomo Dainippon Pharma Co., LTD.
  • Fujifilm Holdings Corporation
  • Thermo Fisher Scientific, Inc.
  • Astellas Pharma Inc.
  • OXGENE
  • Cytiva
  • Exothera
  • Charles River Laboratories
  • Cell Therapies Pty Ltd
  • Bio-Techne
  • Catalent, Inc

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Therapy Type
  • Market Snapshot, By Technology Type
  • Market Snapshot, By Manufacturing Purpose
  • Market Snapshot, By Application
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Cell Therapy Manufacturing Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Cell Therapy Manufacturing Market, By Therapy Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Allogeneic Cell Therapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Autologous Cell Therapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Cell Therapy Manufacturing Market, By Technology Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Somatic Cell Technology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cell Immortalization Technology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Viral Vector Technology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Genome Editing Technology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cell Plasticity Technology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• 3D Technology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Cell Therapy Manufacturing Market, By Manufacturing Purpose, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Clinical
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Commercial
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Pre-clinical
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Cell Therapy Manufacturing Market, By Application, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Musculoskeletal
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cardiovascular
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Gastrointestinal
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Neurological
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Oncology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Dermatology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Cell Therapy Manufacturing Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Purpose, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Purpose, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Purpose, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Purpose, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

• Company Profiles
  • WuXi AppTec, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Lineage Cell Therapeutics, Inc.
  • Healios Ltd.
  • Lonza
  • Merck KGaA
  • Takara Bio Inc.
  • Sumitomo Dainippon Pharma Co., LTD.
  • Fujifilm Holdings Corporation
  • Thermo Fisher Scientific, Inc.
  • Astellas Pharma Inc.
  • OXGENE
  • Cytiva
  • Exothera
  • Charles River Laboratories
  • Cell Therapies Pty Ltd
  • Bio-Techne
  • Catalent, Inc

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact